The clinical success of an ever-increasing array of biologics has led to the development of a wide spectrum of immunomodulatory…
Read MoreSearch results: “Tec”
Showing 49–60 of 81 results
Kinase therapeutics includes both monoclonal antibodies (mAbs) and small-molecule inhibitors. DiscoveRx’s PathHunter® protein: protein interaction system uses well-established Enzyme Fragment…
Read MoreOrphan GPCRs continue to represent a target class with immense potential for the discovery of novel therapeutic compounds. In spite…
Read MoreDiscoveRx previously introduced a protein-protein interaction system using enzyme fragment complementation that provides a robust, HTS friendly format for monitoring…
Read MoreCystic fibrosis (CF) patients have mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel that result in reduced…
Read MoreWith more than 25% of the world’s population diagnosed with type II diabetes and/or metabolic syndrome, the requirement for cost…
Read MoreBoth multi- and single-pass membrane receptors constitutively exhibit complicated and dynamic membrane receptor trafficking as well as internalization induced by…
Read MoreDiscoveRx® has pioneered a novel enzyme complementation system to monitor cellular events such as protein translocation, protein interactions, and degradation…
Read MoreThe cAMP detection technologies are widely used in high throughput screening (HTS) for measuring a functional response of a GPCR…
Read MoreReporter genes are a well-established method used to develop cell-based assays for testing drugs that inhibit or activate targets involved…
Read MoreRegulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many…
Read MoreAssays that directly detect compound binding inside cells can be of great utility in translating in vitro data to more…
Read More